Tumor necrosis factor-alpha inhibits human chorionic gonadotropin secretion

Area of Science:

• Reproductive Endocrinology
• Immunology
• Cell Biology

Background:

• The placenta produces tumor necrosis factor-alpha (TNF alpha) and expresses TNF alpha receptors.
• TNF alpha is known to inhibit human chorionic gonadotropin (hCG) secretion in early pregnancy chorionic villi.
• Previous studies utilized heterogeneous cell populations, necessitating investigation into direct effects on trophoblasts.

Purpose of the Study:

• To investigate the direct impact of TNF alpha on trophoblast cells.
• To determine the effect of TNF alpha on human chorionic gonadotropin (hCG) secretion in vitro.
• To assess the impact of TNF alpha on hCG beta mRNA expression.

Main Methods:

• Utilized the NUC1 choriocarcinoma cell line as an in vitro model for placental trophoblasts.
• Administered varying concentrations of TNF alpha (1-100 U/mL) to NUC1 cells.
• Measured hCG secretion and hCG beta mRNA levels using established assays; assessed cytotoxicity via trypan blue exclusion and MTT assays.

Main Results:

• TNF alpha significantly inhibited hCG secretion in NUC1 cells in a dose-dependent manner.
• hCG secretion decreased to 88%, 81%, and 71% of control levels with 1, 10, and 100 U/mL TNF alpha, respectively.
• A significant decrease in hCG beta mRNA expression (to 23% of control) was observed after 24 hours of TNF alpha treatment (100 U/mL), with inhibition starting after 12 hours. Cytotoxicity was ruled out.

Conclusions:

• TNF alpha directly inhibits hCG secretion in trophoblast cells.
• The observed inhibition of hCG secretion is not attributable to cytotoxic effects of TNF alpha.
• These findings highlight a potential mechanism by which TNF alpha influences placental function and hormone production.